Pascal Ferre
Overview
Explore the profile of Pascal Ferre including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
3995
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bandet C, Tan-Chen S, Ali-Berrada S, Campana M, Poirier M, Blachnio-Zabielska A, et al.
J Biol Chem
. 2023 May;
299(6):104815.
PMID: 37178918
Ceramides have been shown to play a major role in the onset of skeletal muscle insulin resistance and therefore in the prevalence of type 2 diabetes. However, many of the...
2.
3.
Ferre P, Phan F, Foufelle F
Biochem J
. 2021 Oct;
478(20):3723-3739.
PMID: 34673919
Sterol Regulatory Element Binding Protein-1c is a transcription factor that controls the synthesis of lipids from glucose in the liver, a process which is of utmost importance for the storage...
4.
Hajduch E, Lachkar F, Ferre P, Foufelle F
J Clin Med
. 2021 Mar;
10(4).
PMID: 33669443
Non-alcoholic fatty liver disease is one of the most common chronic liver diseases, ranging from simple steatosis to steatohepatitis, fibrosis, and cirrhosis. Its prevalence is rapidly increasing and presently affects...
5.
Carlier A, Phan F, Szpigel A, Hajduch E, Salem J, Gautheron J, et al.
Cell Rep Med
. 2020 Dec;
1(9):100154.
PMID: 33377125
Plasma dihydroceramides are predictors of type 2 diabetes and related to metabolic dysfunctions, but the underlying mechanisms are not characterized. We compare the relationships between plasma dihydroceramides and biochemical and...
6.
Lachkar F, Ferre P, Foufelle F, Papaioannou A
Am J Physiol Endocrinol Metab
. 2020 Nov;
320(1):E122-E130.
PMID: 33135459
Dihydroceramides (DhCers) are a type of sphingolipids that for a long time were regarded as biologically inactive. They are metabolic intermediates of the de novo sphingolipid synthesis pathway, and are...
7.
Lachkar F, Papaioannou A, Ferre P, Foufelle F
Biol Aujourdhui
. 2020 Aug;
214(1-2):15-23.
PMID: 32773026
Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent pathology associated with obesity. It encompasses a spectrum of hepatic disorders ranging from steatosis to non-alcoholic steatohepatitis (NASH), which may lead...
8.
Ceramide Transporter CERT Is Involved in Muscle Insulin Signaling Defects Under Lipotoxic Conditions
Bandet C, Mahfouz R, Veret J, Sotiropoulos A, Poirier M, Giussani P, et al.
Diabetes
. 2018 May;
67(7):1258-1271.
PMID: 29759974
One main mechanism of insulin resistance (IR), a key feature of type 2 diabetes, is the accumulation of saturated fatty acids (FAs) in the muscles of obese patients with type...
9.
Okamoto S, Sato T, Tateyama M, Kageyama H, Maejima Y, Nakata M, et al.
Cell Rep
. 2018 Jan;
22(3):706-721.
PMID: 29346768
Food selection is essential for metabolic homeostasis and is influenced by nutritional state, food palatability, and social factors such as stress. However, the mechanism responsible for selection between a high-carbohydrate ...
10.
Hu M, Phan F, Bourron O, Ferre P, Foufelle F
Biochimie
. 2017 Nov;
143:37-41.
PMID: 29097281
Non Alcoholic Fatty Liver Disease (NAFLD) is currently the most common chronic liver disease in the world, encompassing various conditions ranging from simple steatosis, steatohepatitis, to fibrosis and cirrhosis. The...